Sustainable exploitation of paper mill wastes: a resource to re-use in the paper factory

In the papermaking industry, billions of tonnes of paper mill wastes are globally produced as wastes every year. These include cellulosic and inorganic sludges, which are traditionally landfilled, leading to environmental and economic issues. For these reasons, it is urgent to develop new sustainable strategies to exploit these fractions. Up to now, these sludges have been exploited i) for land application (as soil amendment/substrate), ii) for energy recovery and iii) for the production of bio-composites. However, the above possibilities involve the direct use of the bulk wastes, without fractionating/exploiting each feedstock component. In the perspective of the valorisation of the different components, the present investigation has considered different strategies: i) a thermal treatment, ii) an alkaline and iii) a mechanical one, aimed at the fractionation and recovery of the two main components of cellulosic and inorganic sludge, cellulose and calcium carbonate, respectively, that could be advantageously reused within the same papermaking process

Biomass ethanolysis: process optimization and performances of ethyl levulinate as diesel blendstock

Biomass represents a key asset for renewable energy production in the context of the more and more pressing energetic transition. Moreover, at the present, the issue of how to store a convenient amount of energy on board of electric vehicles is still a challenge and electric vehicles perspectives are limited to passenger cars and very small-range trucks, significant amount of time being necessary to define the eventual appropriate electric storage system to be employed in heavy transport, as well in aviation and shipping. In this context alkyl levulinates represent a concrete perspective for partial replacement of fossil fuel with renewable blendstocks. In particular, ethyl levulinate (EL) production by direct acid-catalyzed biomass ethanolysis was studied in order to investigate and optimize this one-step process which involves only renewable starting materials (biomass and bioethanol). In this perspective, the role of the main reaction parameters as the substrate nature and loading, type of the acid catalyst and its concentration, reaction temperature and duration were studied. EL was tested up to high concentrations in a mixture with diesel fuel in a small single-cylinder air-cooled diesel engine, to verify the engine and emission performances of the different blend compositions respect to those ascertained with a conventional diesel fuel

Mapping genetic determinants of host susceptibility to Pseudomonas aeruginosa lung infection in mice.

Background: P. aeruginosa is one of the top three causes of opportunistic human bacterial infections. The remarkable variability in the clinical outcomes of this infection is thought to be associated with genetic predisposition. However, the genes underlying host susceptibility to P. aeruginosa infection are still largely unknown. Results: As a step towards mapping these genes, we applied a genome wide linkage analysis approach to a mouse model. A large F2 intercross population, obtained by mating P. aeruginosa-resistant C3H/HeOuJ, and susceptible A/J mice, was used for quantitative trait locus (QTL) mapping. The F2 progenies were challenged with a P. aeruginosa clinical strain and monitored for the survival time up to 7 days post-infection, as a disease phenotype associated trait. Selected phenotypic extremes of the F2 distribution were genotyped with high-density single nucleotide polymorphic (SNP) markers, and subsequently QTL analysis was performed. A significant locus was mapped on chromosome 6 and was named P. aeruginosa infection resistance locus 1 (Pairl1). The most promising candidate genes, including Dok1, Tacr1, Cd207, Clec4f, Gp9, Gata2, Foxp1, are related to pathogen sensing, neutrophils and macrophages recruitment and inflammatory processes. Conclusions: We propose a set of genes involved in the pathogenesis of P. aeruginosa infection that may be explored to complement human studie

Cystic Fibrosis-Niche Adaptation of Pseudomonas aeruginosa Reduces Virulence in Multiple Infection Hosts

The opportunistic pathogen Pseudomonas aeruginosa is able to thrive in diverse ecological niches and to cause serious human infection. P. aeruginosa environmental strains are producing various virulence factors that are required for establishing acute infections in several host organisms; however, the P. aeruginosa phenotypic variants favour long-term persistence in the cystic fibrosis (CF) airways. Whether P. aeruginosa strains, which have adapted to the CF-niche, have lost their competitive fitness in the other environment remains to be investigated. In this paper, three P. aeruginosa clonal lineages, including early strains isolated at the onset of infection, and late strains, isolated after several years of chronic lung infection from patients with CF, were analysed in multi-host model systems of acute infection. P. aeruginosa early isolates caused lethality in the three non-mammalian hosts, namely Caenorhabditis elegans, Galleria mellonella, and Drosophila melanogaster, while late adapted clonal isolates were attenuated in acute virulence. When two different mouse genetic background strains, namely C57Bl/6NCrl and Balb/cAnNCrl, were used as acute infection models, early P. aeruginosa CF isolates were lethal, while late isolates exhibited reduced or abolished acute virulence. Severe histopathological lesions, including high leukocytes recruitment and bacterial load, were detected in the lungs of mice infected with P. aeruginosa CF early isolates, while late isolates were progressively cleared. In addition, systemic bacterial spread and invasion of epithelial cells, which were detected for P. aeruginosa CF early strains, were not observed with late strains. Our findings indicate that niche-specific selection in P. aeruginosa reduced its ability to cause acute infections across a broad range of hosts while maintaining the capacity for chronic infection in the CF host

The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy

The recent focus on the cystic fibrosis (CF) complex microbiome has led to the recognition that the microbes can interact between them and with the host immune system, affecting the disease progression and treatment routes. Although the main focus remains on the interactions between traditional pathogens, growing evidence supports the contribution and the role of emergent species. Understanding the mechanisms and the biological effects involved in polymicrobial interactions may be the key to improve effective therapies and also to define new strategies for disease control. This review focuses on the interactions between microbe-microbe and host-microbe, from an ecological point of view, discussing their impact on CF disease progression. There are increasing indications that these interactions impact the success of antimicrobial therapy. Consequently, a new approach where therapy is personalized to patients by taking into account their individual CF microbiome is suggested.Portuguese Foundation for Science and Technology (FCT), the strategic funding of UID/BIO/04469/2013-CEB and UID/EQU/00511/2013-LEPABE units. This study was also supported by FCT and the European Community fund FEDER, through Program COMPETE, under the scope of the Projects “DNA mimics” PIC/IC/82815/2007, RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462), “BioHealth—Biotechnology and Bioengineering approaches to improve health quality”, Ref. NORTE-07-0124-FEDER-000027 and NORTE-07-0124-FEDER-000025—RL2_ Environment and Health, co-funded by the Programa Operacional Regional do Norte (ON.2 – O Novo Norte), QREN, FEDER. The authors also acknowledge the grant of Susana P. Lopes (SFRH/BPD/95616/2013) and of the COST-Action TD1004: Theragnostics for imaging and therapy

Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome

The aim of this paper was to evaluate the efficacy and safety of topical cyclosporine applied as mouthwash in the treatment of burning mouth syndrome (BMS)

Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome

The aim of this paper was to evaluate the efficacy and safety of topical cyclosporine applied as mouthwash in the treatment of burning mouth syndrome (BMS)

The role of pulmonary infection in pediatric asthma

Recently, several authors have documented that respiratory infections may cause wheezing and acute exacerbation of asthma in children. Respiratory syncytial virus infections have been recognized to produce the first episode of wheezing in children who go on to develop chronic asthma. Furthermore, repeated infections caused by other common childhood viral pathogens have been proposed to affect responses of the immune system in such a way as to prevent the onset of allergic diseases and possibly asthma. Recently, it became clear that also infections by intracellular pathogens, such as Chlamydia and Mycoplasma, may cause acute and chronic wheezing in some individuals. In this review we describe the immunologic and clinical implications of the association between respiratory infections and asthma